Generics 17

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Ethinylestradiol manufacturers

17 products found

Filters

Filters

Filters , active

Country of origin : Brazil

Clear all

17 products found

ethinylestradiol + gestodene

Tablets, film coated 0,06mg+0,015mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Brazil
Manufacturer #441

Manufacturer usually replies in nan days

ethinylestradiol + levonorgestrel

Tablets 0,1mg+0,02mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Brazil
Manufacturer #441

Manufacturer usually replies in nan days

drospirenone + ethinylestradiol

Tablets, film coated 3mg+0,03mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Brazil
GMP approvals
ANVISA
Manufacturer #18979
The company has stood out in the national pharmaceutical market and is currently among the top 20 laboratories in the ranking, according to the IMS. The mission expresses the commitment to working towards health and meeting the needs of the population, ethically, seeking to gain more and more the trust of doctors and consumers. Its distribution network of medicines MIP (medicines without prescription) is present throughout the national territory and the activity of propagation of medicines with the medical class expands gradually, reaching today 24 states of the federation.

Manufacturer usually replies in 3 days

levonorgestrel + ethinylestradiol

Tablets, film coated 0,15 mg + 0,03 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Brazil
GMP approvals
ANVISA
Manufacturer #18979
The company has stood out in the national pharmaceutical market and is currently among the top 20 laboratories in the ranking, according to the IMS. The mission expresses the commitment to working towards health and meeting the needs of the population, ethically, seeking to gain more and more the trust of doctors and consumers. Its distribution network of medicines MIP (medicines without prescription) is present throughout the national territory and the activity of propagation of medicines with the medical class expands gradually, reaching today 24 states of the federation.

Manufacturer usually replies in 3 days

cyproterone acetate + ethinylestradiol

Tablets, film coated 2mg + 0,035m

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Brazil
GMP approvals
ANVISA
Manufacturer #18979
The company has stood out in the national pharmaceutical market and is currently among the top 20 laboratories in the ranking, according to the IMS. The mission expresses the commitment to working towards health and meeting the needs of the population, ethically, seeking to gain more and more the trust of doctors and consumers. Its distribution network of medicines MIP (medicines without prescription) is present throughout the national territory and the activity of propagation of medicines with the medical class expands gradually, reaching today 24 states of the federation.

Manufacturer usually replies in 3 days

gestodene + ethinylestradiol

Tablets, film coated 0,075 mg + 0,03 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Brazil
GMP approvals
ANVISA
Manufacturer #18979
The company has stood out in the national pharmaceutical market and is currently among the top 20 laboratories in the ranking, according to the IMS. The mission expresses the commitment to working towards health and meeting the needs of the population, ethically, seeking to gain more and more the trust of doctors and consumers. Its distribution network of medicines MIP (medicines without prescription) is present throughout the national territory and the activity of propagation of medicines with the medical class expands gradually, reaching today 24 states of the federation.

Manufacturer usually replies in 3 days

cyproterone acetate + ethinylestradiol

Tablets, film coated 2mg + 0,035mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Brazil
GMP approvals
ANVISA
Manufacturer #18979
The company has stood out in the national pharmaceutical market and is currently among the top 20 laboratories in the ranking, according to the IMS. The mission expresses the commitment to working towards health and meeting the needs of the population, ethically, seeking to gain more and more the trust of doctors and consumers. Its distribution network of medicines MIP (medicines without prescription) is present throughout the national territory and the activity of propagation of medicines with the medical class expands gradually, reaching today 24 states of the federation.

Manufacturer usually replies in 3 days

drospirenone + ethinylestradiol

Tablets 3 mg + 0.03 mg, 3 mg + 0.02 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Brazil
GMP approvals
ANVISA
Manufacturer #18978
The company is focused to bring quality to the needs of people's lives. The company is focused on innovation, lifestyle, and freedom. The company continues the maintenance of its leadership position with new products and entry into new markets.

Manufacturer usually replies in 4 days

gestodene + ethinylestradiol

Tablets, film coated 75 mcg + 30 mcg, 60 mcg + 15 mcg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Brazil
GMP approvals
ANVISA
Manufacturer #463

Manufacturer usually replies in 11 days

desogestrel + ethinylestradiol

Tablets 150 mcg + 30mcg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Brazil
GMP approvals
ANVISA
Manufacturer #463

Manufacturer usually replies in 11 days

cyproterone + ethinylestradiol

Tablets 0.04 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Brazil
GMP approvals
ANVISA
Manufacturer #463

Manufacturer usually replies in 11 days

drospirenone + ethinylestradiol

Tablets, film coated 0.02 mg, 0.03 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Brazil
GMP approvals
ANVISA
Manufacturer #463

Manufacturer usually replies in 11 days

chlormadinone + ethinylestradiol

Tablets, enteric coated 2mg+0.03mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Brazil
GMP approvals
ANVISA
Manufacturer #18738
It was founded in the 1990s. It is a partner of advanced research laboratories in the area of health in various countries and encourages the development of new therapeutic approaches. Attention to technological development and innovations in the pharmaceutical industry provides excellence in the company’s product lines.

levonorgestrel + ethinylestradiol

Tablets 0,15mg+0,03mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Brazil
GMP approvals
ANVISA
Manufacturer #19185
The company develops, produces, and sells medicines and eyewear, meeting public health policies. It has more than 50 years of history marked by a history of success and good practices.

Manufacturer usually replies in nan days

levonorgestrel + ethinylestradiol

Tablets 0,25mg+0,05mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Brazil
Manufacturer #441

Manufacturer usually replies in nan days

levonorgestrel + ethinylestradiol

Tablets 0,15mg+0,03mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Brazil
Manufacturer #441

Manufacturer usually replies in nan days

chlormadinone + ethinylestradiol

Tablets, film coated 2 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Brazil
GMP approvals
ANVISA
Manufacturer #463

Manufacturer usually replies in 11 days

Ethinylestradiol Uses

Ethinylestradiol is an estrogen medication that widely used in birth control pills in combination with Progestins. In the past, Ethinylestradiol was earlier prescribed to treat various indications such as menopausal symptoms, gynecological disorders, and certain hormone-sensitive cancers. Ethinylestradiol is agonist of the estrogen receptors, the biological target of estrogens like estradiol. It is a synthetic derivative of estradiol, a natural estrogen but differs from it in various ways. Compared to estradiol, Ethinylestradiol has greatly improved bioavailability when taken by mouth, in addition to being more resistant to metabolism. It also shows relatively better efficacy in certain parts of the body like the liver and uterus. These differences make Ethinylestradiol more favorable for use in birth control pills than estradiol. However, high usage can Increase the risk of blood clots and certain other rare adverse side effects.
Ethinylestradiol was the first orally active synthetic estrogen and was described in 1938 by Hans Herloff Inhoffen and Walter Hohlweg of Schering AG in Berlin. Schering got the first approval from the FDA in 1943. It is marketed under the brand name Estinyl. However, it only started being used as birth control pills later in the 1960s. Today, Ethinylestradiol is the exclusive estrogen used for this purpose, making it one of if not the most widely used estrogens. The FDA withdrew approval of Estinyl effective in 2004 at the request of Schering, which had discontinued marketing it. However, the given the obvious societal benefits of the medicine, It is manufactured and sold under several brand names by global and local manufacturers and labelers.

Forms and Dosage

Ethinylestradiol was previously available by itself under the brand name Estinyl in the form of 0.02, 0.05, and 0.5 mg (20, 50, and 500 µg) tablets. It is usually taken by mouth but is also used as a patch and vaginal ring. Ethinylestradiol is available in combination with a progestin as a transdermal contraceptive patch and as a contraceptive vaginal ring. In addition, there is a single preparation containing very low doses of Ethinylestradiol plus a progestin in an oral tablet that remains in use for menopausal hormone therapy.

The cost of Ethinylestradiol

For bulk industrial usage, the powder form is sold commercially at about USD 500. However, one of the commonly sold brands sells for about USD 100 for monthly supply of 30 tablets. In developing world, the price of imported powder is can vary between USD 15-30 due to domestic manufacturers.

How does Ethinylestradiol work?

Ethinylestradiol is a synthetic estrogenic compound. Use of estrogens have a number of effects on the body including reduced bone density. Combined oral contraceptives suppress ovulation by thickening the cervical mucus to prevent sperm from traveling, and preventing changes in the endometrium required in the implantation of a fertilized egg.

Finding Ethinylestradiol Manufacturers and Ethinylestradiol Suppliers

One of the fastest and easiest ways to find Ethinylestradiol manufacturers and Ethinylestradiol suppliers is to make use of Pipelinepharma's global B2B online marketplace for medicines and other pharmaceuticals.
Usually, finding trusted manufacturers and supplies of specific drugs like Ethinylestradiol can be a time-consuming challenge, but with Pipelinepharma's simple search engine and network of proven partners, the whole process becomes a lot easier.
All you need to do to get started is make use of our integrated search engine and start looking for suppliers or manufacturers of Ethinylestradiol to work with. You can fine-tune your search results using various filters too, letting you search for Ethinylestradiol from specific countries.